SUPERNUS PHARMACEUTICALS, INC. (SUPN) Form 8-K — Oct 19, 2026

$SUPNForm 8-KItems 2.02, 9.01Filed Oct 19, 2026, 4:51 PM ET0001356576-26-000043Original filing

Supernus Pharmaceuticals (Nasdaq: SUPN) announced it will report third quarter 2026 financial and business results after the market closes on Thursday, October 29, 2026. CEO Jack Khattar and CFO Tim Dec will host a conference call and webcast at 4:30 p.m. ET that day, with a live webcast available on the company's investor relations website and a replay available for 60 days.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.